Evidence map›Paper›PMID 41553759›Full record

ArticleeLife2026

GMCL1 controls 53BP1 stability and modulates taxane sensitivity.

Yuki Kito, Tania J González-Robles, Sharon Kaisari, Juhee Pae, Sheena Faye Garcia, Juliana Ortiz-Pacheco, Beatrix Ueberheide, Antonio Marzio, Gergely Róna, Michele Pagano

Abstract read
In one paragraph

Article in eLife, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors.

Yuki KitoDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, United States.ORCID https://orcid.org/0000-0001-5104-0932
Tania J González-RoblesDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, United States.ORCID https://orcid.org/0000-0001-9292-382X
Sharon KaisariDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, United States.ORCID https://orcid.org/0000-0002-6884-3886
Juhee PaeDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, United States.
Sheena Faye GarciaDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, United States.
Juliana Ortiz-PachecoDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, United States.
Beatrix UeberheideDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, United States.ORCID https://orcid.org/0000-0003-2512-0204
Antonio MarzioDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, United States.ORCID https://orcid.org/0000-0001-5959-012X
Gergely RónaDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, United States.ORCID https://orcid.org/0000-0003-3222-7261
Michele PaganoDepartment of Biochemistry and Molecular Pharmacology, New York University Grossman School of Medicine, New York, United States.ORCID https://orcid.org/0000-0003-3210-2442

Funding

Vaccine FacilityP30CA016087 · NCI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MARK Reid PHILIPS · 1985 to 2026
$83.1M
Training Program in Cell BiologyT32GM136542 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SMITH, SUSAN · 2020 to 2024
$3.0M
Regulation of the cell proliferation by CRL ubiquitin ligases-diversity supplementR35GM136250 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI MICHELE PAGANO · 2020 to 2026
$2.7M
Elucidating the Role of the Tumor Suppressor KEAP1 in Antitumor ImmunityR01CA296867 · NCI · WEILL MEDICAL COLL OF CORNELL UNIV · PI Antonio Marzio · 2025 to 2026
$1.0M
Elucidating the role of cyclin D1-CDK4/6 in protein homeostasis.K99GM155613 · NIGMS · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI Sharon Kaisari · 2025 to 2026
$250k
European Molecular Biology Organization IG5670-2024Howard Hughes Medical Institute GT15758Hungarian Academy of Sciences LP2023-15/2023Hungarian Research Network KSZF-143/2023NCI NIH HHS P30 CA016087NCI NIH HHS P30CA016087NCI NIH HHS R01 CA296867NCI NIH HHS R01 CA296867-01A1NIGMS NIH HHS 1K99GM155613-01A1NIGMS NIH HHS K99 GM155613NIGMS NIH HHS R35 GM136250NIGMS NIH HHS T32 GM136542NIH HHS R35-GM136250NIH Office of the Director T32GM136542United States Department of Defense HT9425-24-1-0019
6 · The paper itself

Abstract

Mitotic surveillance pathways monitor the duration of mitosis (M phase) in the cell cycle. Prolonged M phase, caused by spindle attachment defects or microtubule-targeting drugs, triggers formation of the ternary 'mitotic stopwatch pathway' complex (MSP) consisting of 53BP1, USP28, and p53. This complex stabilizes p53, leading to cell cycle arrest or apoptosis in daughter cells. In cancers that are resistant to paclitaxel, a microtubule-targeting agent, cells bypass mitotic surveillance activation, allowing unchecked proliferation, although the underlying mechanisms remain poorly understood. Here, we identify GMCL1 as a key negative regulator of MSP signaling. We show that 53BP1 physically interacts with GMCL1, but not its paralog GMCL2, and we map their interaction domains. CRL3

Indexed as

PaclitaxelTaxoidsTumor Suppressor p53-Binding Protein 1Cell Line, TumorDrug Resistance, NeoplasmHumansMitosisProtein StabilityProteolysisTumor Suppressor Protein p53Ubiquitin ThiolesterasePaclitaxelTaxoidsTP53BP1 protein, humanTumor Suppressor p53-Binding Protein 1Tumor Suppressor Protein p53Ubiquitin Thiolesterase53BP1cancer biologycell biologyGMCL1humanmitotic stopwatchp53prolonged mitosisprotein degradation

Identifiers

PMID41553759
PMCPMC12815461

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.